{"id":"https://openalex.org/W2046254173","doi":"https://doi.org/10.7326/0003-4819-123-3-199508010-00001","title":"Effects of Naloxone Infusions in Patients with the Pruritus of Cholestasis: A Double-Blind, Randomized, Controlled Trial","display_name":"Effects of Naloxone Infusions in Patients with the Pruritus of Cholestasis: A Double-Blind, Randomized, Controlled Trial","publication_year":1995,"publication_date":"1995-08-01","ids":{"openalex":"https://openalex.org/W2046254173","doi":"https://doi.org/10.7326/0003-4819-123-3-199508010-00001","mag":"2046254173","pmid":"https://pubmed.ncbi.nlm.nih.gov/7598296"},"language":"en","primary_location":{"id":"doi:10.7326/0003-4819-123-3-199508010-00001","doi":"https://doi.org/10.7326/0003-4819-123-3-199508010-00001","is_oa":false,"landing_page_url":"https://doi.org/10.7326/0003-4819-123-3-199508010-00001","pdf_url":null,"source":{"id":"https://openalex.org/S119722071","display_name":"Annals of Internal Medicine","issn_l":"0003-4819","issn":["0003-4819","1539-3704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316812","host_organization_name":"American College of Physicians","host_organization_lineage":["https://openalex.org/P4310316812"],"host_organization_lineage_names":["American College of Physicians"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Internal Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108797080","display_name":"Nora V. Bergasa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nora Valeria Bergasa","raw_affiliation_strings":["From the National Institutes of Health, Bethesda, Maryland","National Institutes of Health, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238"]},{"raw_affiliation_string":"National Institutes of Health, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091478218","display_name":"David W. Alling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David W. Alling","raw_affiliation_strings":["From the National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025777431","display_name":"THOMAS L. TALBOT","orcid":"https://orcid.org/0000-0002-4658-4115","observed_orcids":["https://orcid.org/0000-0002-4658-4115"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas L. Talbot","raw_affiliation_strings":["From the National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109146159","display_name":"Mark G. Swain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark G. Swain","raw_affiliation_strings":["From the National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088602858","display_name":"Cihan Yurdayd\u0131n","orcid":"https://orcid.org/0000-0002-5419-7158","observed_orcids":["https://orcid.org/0000-0002-5419-7158"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cihan Yurdaydin","raw_affiliation_strings":["From the National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112798861","display_name":"Maria L Chanco Turner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria L. Turner","raw_affiliation_strings":["From the National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052276048","display_name":"Joseph M. Schmitt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph M. Schmitt","raw_affiliation_strings":["From the National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072700988","display_name":"Elijah C. Walker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elijah C. Walker","raw_affiliation_strings":["From the National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108390962","display_name":"E. Anthony Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Anthony Jones","raw_affiliation_strings":["From the National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1299303238"],"apc_list":null,"apc_paid":null,"fwci":13.6114,"has_fulltext":false,"cited_by_count":363,"citation_normalized_percentile":{"value":0.99107807,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"123","issue":"3","first_page":"161","last_page":"167"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9434000253677368,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9434000253677368,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11834","display_name":"Liver Diseases and Immunity","score":0.011800000444054604,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.0052999998442828655,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/naloxone","display_name":"naloxone","score":0.9309999942779541},{"id":"https://openalex.org/keywords/endogenous-opioids","display_name":"endogenous opioids","score":0.8519999980926514},{"id":"https://openalex.org/keywords/opioid-receptor-antagonism","display_name":"opioid antagonism","score":0.6729999780654907},{"id":"https://openalex.org/keywords/scratching-behavior","display_name":"scratching behavior","score":0.7630000114440918},{"id":"https://openalex.org/keywords/cholestatic-liver-disease","display_name":"cholestatic liver disease","score":0.7649999856948853},{"id":"https://openalex.org/keywords/opioid-withdrawal","display_name":"opioid withdrawal","score":0.6140000224113464}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9146019816398621},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.7479673624038696},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7168979048728943},{"id":"https://openalex.org/C2780196728","wikidata":"https://www.wikidata.org/wiki/Q1413166","display_name":"Scratching","level":2,"score":0.6200032234191895},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.6053917407989502},{"id":"https://openalex.org/C2778140631","wikidata":"https://www.wikidata.org/wiki/Q2026938","display_name":"Opiate","level":3,"score":0.5742026567459106},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.5512068867683411},{"id":"https://openalex.org/C14184104","wikidata":"https://www.wikidata.org/wiki/Q1362526","display_name":"Visual analogue scale","level":2,"score":0.5508912205696106},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.49616631865501404},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.48650068044662476},{"id":"https://openalex.org/C3019590667","wikidata":"https://www.wikidata.org/wiki/Q908096","display_name":"Narcotic antagonist","level":5,"score":0.476468563079834},{"id":"https://openalex.org/C2775962371","wikidata":"https://www.wikidata.org/wiki/Q908096","display_name":"Opioid antagonist","level":5,"score":0.4584474265575409},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4378129541873932},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35374754667282104},{"id":"https://openalex.org/C24890656","wikidata":"https://www.wikidata.org/wiki/Q82811","display_name":"Acoustics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002779","descriptor_name":"Cholestasis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009270","descriptor_name":"Naloxone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009270","descriptor_name":"Naloxone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009270","descriptor_name":"Naloxone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.7326/0003-4819-123-3-199508010-00001","doi":"https://doi.org/10.7326/0003-4819-123-3-199508010-00001","is_oa":false,"landing_page_url":"https://doi.org/10.7326/0003-4819-123-3-199508010-00001","pdf_url":null,"source":{"id":"https://openalex.org/S119722071","display_name":"Annals of Internal Medicine","issn_l":"0003-4819","issn":["0003-4819","1539-3704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316812","host_organization_name":"American College of Physicians","host_organization_lineage":["https://openalex.org/P4310316812"],"host_organization_lineage_names":["American College of Physicians"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Internal Medicine","raw_type":"journal-article"},{"id":"pmid:7598296","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7598296","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of internal medicine","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W1495781935","https://openalex.org/W1510301222","https://openalex.org/W1707963585","https://openalex.org/W1989333859","https://openalex.org/W2002747090","https://openalex.org/W2021142183","https://openalex.org/W2022723969","https://openalex.org/W2053933941","https://openalex.org/W2060038083","https://openalex.org/W2065323160","https://openalex.org/W2086368973","https://openalex.org/W2114772172","https://openalex.org/W2117643024","https://openalex.org/W2124510257","https://openalex.org/W2141873077","https://openalex.org/W2157212836","https://openalex.org/W2168681401","https://openalex.org/W2168745915","https://openalex.org/W2282306843","https://openalex.org/W2395129770","https://openalex.org/W2414119891","https://openalex.org/W2983794673"],"related_works":["https://openalex.org/W1495781935","https://openalex.org/W2712780427","https://openalex.org/W2328848004","https://openalex.org/W2046073416","https://openalex.org/W2098877656","https://openalex.org/W2059876429","https://openalex.org/W2008756039","https://openalex.org/W2082955455","https://openalex.org/W4387497485","https://openalex.org/W1967622037"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"determine":[2],"whether":[3],"endogenous":[4,265],"opioids":[5,266],"contribute":[6],"to":[7,123,177,195,204],"the":[8,14,17,22,85,155,183,186,226,240,245,252,258,277],"pruritus":[9,25,91,158,229,259],"of":[10,16,24,35,57,90,104,130,137,149,154,157,185,225,228,232,239,244,247,260,279,282],"cholestasis":[11,261],"by":[12,264],"studying":[13],"effect":[15],"opiate":[18,124,270],"antagonist":[19],"naloxone":[20,68,163,193],"on":[21,27],"perception":[23,156,227],"and":[26,69,209,230,267],"scratching":[28,101,131,190,233],"activity":[29,102,132,191,234],"in":[30,75,135,214,235,276],"patients":[31,53,98,139],"with":[32,42,54,118,223],"this":[33,280],"form":[34],"pruritus.":[36],"DESIGN:":[37],"Double-blind,":[38],"placebo-controlled,":[39],"crossover":[40],"trial":[41],"four":[43],"periods.":[44],"SETTING:":[45],"Clinical":[46],"research":[47],"referral":[48],"center.":[49],"PATIENTS:":[50],"29":[51],"pruritic":[52],"liver":[55],"diseases":[56],"various":[58],"causes.":[59],"INTERVENTION:":[60],"Each":[61,78],"patient":[62,112],"received":[63],"as":[64,66],"many":[65],"two":[67,70],"placebo":[71,172,198],"solution":[72],"infusions":[73,164,173,194,199],"consecutively":[74],"random":[76],"order.":[77],"infusion":[79],"lasted":[80],"24":[81],"hours.":[82],"MEASUREMENTS:":[83],"During":[84],"infusions,":[86],"visual":[87,151],"analog":[88,152],"scores":[89],"were":[92,99,145],"recorded":[93,108,161,170],"every":[94],"4":[95],"hours":[96],"while":[97],"awake;":[100],"independent":[103],"limb":[105],"movements":[106],"was":[107,133,165,200,210],"continuously.":[109],"RESULTS:":[110],"One":[111],"had":[113],"a":[114,119,150,255,274],"mild":[115],"reaction":[116],"consistent":[117],"naloxone-precipitated":[120],"syndrome":[121],"similar":[122],"withdrawal.":[125],"A":[126],"significant":[127],"24-hour":[128],"rhythm":[129],"seen":[134],"7":[136],"11":[138],"for":[140],"whom":[141],"complete":[142],"96-hour":[143],"data":[144],"collected.":[146],"The":[147],"mean":[148,188],"score":[153],"(maximum,":[159],"10.0)":[160],"during":[162,171,192,197],"0.582":[166],"lower":[167],"than":[168,212],"that":[169,196,254,269],"(95%":[174],"CI,":[175],"0.176":[176],"0.988;":[178],"P":[179,206],"<":[180,207],"0.01).":[181],"Furthermore,":[182],"ratio":[184],"geometric":[187],"hourly":[189],"0.727":[201],"(CI,":[202],"0.612":[203],"0.842;":[205],"0.001)":[208],"greater":[211],"1.0":[213],"only":[215],"five":[216],"patients.":[217,237],"CONCLUSIONS:":[218],"Naloxone":[219],"administration":[220],"is":[221,262],"associated":[222],"amelioration":[224],"reduction":[231],"cholestatic":[236],"Because":[238],"opioid":[241],"receptor":[242],"specificity":[243],"action":[246],"naloxone,":[248],"these":[249],"findings":[250],"support":[251],"hypothesis":[253],"mechanism":[256],"underlying":[257],"modulated":[263],"suggest":[268],"antagonists":[271],"may":[272],"have":[273],"role":[275],"management":[278],"complication":[281],"cholestasis.":[283]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":15},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}